In human studies, the serum concentration of IL-18 was found to be significantly higher in patients with metabolic syndrome, type 2 diabetes mellitus, or diabetic nephropathy compared with healthy control participants [9–11]. This evidence concerns the gene IL18 and diabetic kidney disease.